Contact:
Ronald C. Trahan, APR
President/CEO
Ronald Trahan Associates ("RTA")
5 Walpole St.
Norwood MA USA 02062
781-762-9782 ext 18 phone
781-769-9782 fax http://www.ronaldtrahan.com
RONALD TRAHAN ASSOCIATES ("RTA")
INC. TO LAUNCH SINGLESOURCE EXPERTISE(TM) AT MEDTECH INSIGHT'S "INVESTMENT
IN INNOVATION" CONFERENCE IR/PR firm's unique offering to debut at conference Position private
companies for fund-raising activities
NORWOOD MA USA: Ronald Trahan Associates ("RTA") Inc. announced
today that it is launching its new SingleSource Expertise(TM) program at Medtech
Insight's "Investment In Innovation: A Preview of Early-Stage Medical
Technology Companies (In3)" conference in Boston on Oct. 30-31, 2003,
at the Westin Copley Place Hotel.
RTA's unique product combines analyst research and corporate advisory services,
along with the firm's traditional public and investor relations offerings, to
position private companies for fund-raising activities.
RTA, founded in 1992, is a PR/IR firm focused on serving big and small companies,
both public and private, in the life sciences industry including biotech, medical
technology and pharmaceutical companies, as well as trade-related associations
and organizations.
LAYS THE GROUNDWORK FOR COMPANIES SEEKING FINANCING
"We anticipate that SingleSource Expertise will be a tremendous success,
since it fills a huge void that currently exists in the marketplace, by offering
companies the opportunity to receive both validation through a credible research
report and visibility through our PR/IR campaigns," says Ronald C. Trahan,
APR, President, CEO and Founder of Ronald Trahan Associates Inc.
"The fundraising landscape for companies has changed dramatically in recent
years, and we believe RTA is among the first firms to address this 'new world
order' by offering SingleSource Expertise that lays the groundwork for companies
seeking financing."
Trahan explains that, "Our approach is unique since RTA and its SingleSource
Expertise affiliates execute several powerful strategies - including media,
research and IR -- that all blend together at the right time to raise a company's
profile and prepare it for a successful capital raise."
Sharon O'Reilly, President & CEO of Medtech Insight, LLC, says, "We
are proud to have RTA as one of the sponsors of our event, and we are pleased
that RTA has chosen our conference to debut its new SingleSource Expertise service.
With more than 50 emerging medical technology companies seeking funding, acquisition,
and/or strategic partnerships at our Boston conference, this will be the perfect
venue for both RTA and our presenting companies to consider mutually beneficial
opportunities."
"Investment In Innovation (In3): A Preview of Early-Stage Medical Technology
Companies," is expected to be attended by approximately 350 senior executives
representing the major medical technology companies and investment firms.
Ronald Trahan Associates is a Partner firm of Public Relations Organisation
International, Inc. (PROI), with more than 50 offices worldwide.
